IL91788A - Quinolyloxazol-2-Onim, a process for their preparation and pharmaceutical preparations containing them - Google Patents
Quinolyloxazol-2-Onim, a process for their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL91788A IL91788A IL9178889A IL9178889A IL91788A IL 91788 A IL91788 A IL 91788A IL 9178889 A IL9178889 A IL 9178889A IL 9178889 A IL9178889 A IL 9178889A IL 91788 A IL91788 A IL 91788A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- group
- alkyl
- formula
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/261,435 US4886811A (en) | 1988-10-24 | 1988-10-24 | Qunolyloxazole-2-ones useful as proteinkinase C inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
IL91788A0 IL91788A0 (en) | 1990-06-10 |
IL91788A true IL91788A (en) | 1994-04-12 |
Family
ID=22993289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9178889A IL91788A (en) | 1988-10-24 | 1989-09-26 | Quinolyloxazol-2-Onim, a process for their preparation and pharmaceutical preparations containing them |
Country Status (21)
Country | Link |
---|---|
US (1) | US4886811A (sv) |
EP (1) | EP0365863B1 (sv) |
JP (2) | JP2879454B2 (sv) |
KR (1) | KR0162637B1 (sv) |
CN (1) | CN1025854C (sv) |
AR (1) | AR246733A1 (sv) |
AT (1) | ATE110074T1 (sv) |
AU (1) | AU613302B2 (sv) |
CA (1) | CA2000804C (sv) |
DE (1) | DE68917556T2 (sv) |
DK (1) | DK461389A (sv) |
ES (1) | ES2061863T3 (sv) |
FI (1) | FI93112C (sv) |
HU (1) | HUT58088A (sv) |
IE (1) | IE893011L (sv) |
IL (1) | IL91788A (sv) |
NO (1) | NO894210L (sv) |
NZ (1) | NZ230718A (sv) |
PH (1) | PH27450A (sv) |
PT (1) | PT91870B (sv) |
ZA (1) | ZA897259B (sv) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5036093A (en) * | 1987-10-09 | 1991-07-30 | Du Pont Merck Pharmaceutical | Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents |
DE3907414A1 (de) * | 1989-03-08 | 1990-09-13 | Hoechst Ag | Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen |
US5182293A (en) * | 1989-11-13 | 1993-01-26 | Merrell Dow Pharmaceuticals Inc. | Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
US5190957A (en) * | 1989-11-13 | 1993-03-02 | Merrell Dow Pharmaceuticals Inc. | Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones |
ZA908936B (en) * | 1989-11-13 | 1991-09-25 | Merrell Dow Pharma | Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones |
PH27309A (en) * | 1989-11-13 | 1993-05-28 | Merrell Dow Pharma | Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CA2162586C (en) * | 1993-05-13 | 2006-01-03 | David J. Grainger | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
GB9819382D0 (en) * | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
GB9929216D0 (en) * | 1999-12-11 | 2000-02-02 | Univ Bristol | Isoquinoline and Quinoline Containing substances |
WO2006130090A1 (en) * | 2005-06-03 | 2006-12-07 | Pronas Pharma Ab | Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3025215A (en) * | 1959-07-29 | 1962-03-13 | Monsanto Chemicals | Bis (8-quinolyl carbonate) derivatives |
US3857877A (en) * | 1973-01-12 | 1974-12-31 | Karamchand Premchand Private | 8-hydroxy quinoline derivatives |
US4565820A (en) * | 1980-07-28 | 1986-01-21 | Pfizer Inc. | Hypoglycemic 5-pyrrolyl, indolyl and quinolyl substituted oxazolidine-2,4-diones and their use |
GB8505492D0 (en) * | 1985-03-04 | 1985-04-03 | Roussel Lab Ltd | Chemical compounds |
US4738972A (en) * | 1985-05-21 | 1988-04-19 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
US4673680A (en) * | 1985-09-18 | 1987-06-16 | Pendleton Robert G | α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility |
US4728661A (en) * | 1985-11-13 | 1988-03-01 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic phenyl oxazolones |
US4698353A (en) * | 1985-11-13 | 1987-10-06 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic heterocyclic oxazolones |
US4670450A (en) * | 1985-11-13 | 1987-06-02 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic thiazolones |
US4681940A (en) * | 1985-11-19 | 1987-07-21 | American Home Products Corporation | 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles |
-
1988
- 1988-10-24 US US07/261,435 patent/US4886811A/en not_active Expired - Fee Related
-
1989
- 1989-09-19 DK DK461389A patent/DK461389A/da not_active Application Discontinuation
- 1989-09-20 FI FI894459A patent/FI93112C/sv not_active IP Right Cessation
- 1989-09-20 NZ NZ230718A patent/NZ230718A/en unknown
- 1989-09-20 IE IE893011A patent/IE893011L/xx unknown
- 1989-09-22 ZA ZA897259A patent/ZA897259B/xx unknown
- 1989-09-26 IL IL9178889A patent/IL91788A/en not_active IP Right Cessation
- 1989-09-28 AT AT89118016T patent/ATE110074T1/de not_active IP Right Cessation
- 1989-09-28 DE DE68917556T patent/DE68917556T2/de not_active Expired - Fee Related
- 1989-09-28 EP EP89118016A patent/EP0365863B1/en not_active Expired - Lifetime
- 1989-09-28 ES ES89118016T patent/ES2061863T3/es not_active Expired - Lifetime
- 1989-10-02 PT PT91870A patent/PT91870B/pt not_active IP Right Cessation
- 1989-10-04 AU AU42493/89A patent/AU613302B2/en not_active Ceased
- 1989-10-06 AR AR89315105A patent/AR246733A1/es active
- 1989-10-16 CA CA002000804A patent/CA2000804C/en not_active Expired - Fee Related
- 1989-10-17 CN CN89107938A patent/CN1025854C/zh not_active Expired - Fee Related
- 1989-10-23 HU HU895410A patent/HUT58088A/hu unknown
- 1989-10-23 KR KR1019890015207A patent/KR0162637B1/ko not_active IP Right Cessation
- 1989-10-23 NO NO89894210A patent/NO894210L/no unknown
- 1989-10-24 JP JP1275130A patent/JP2879454B2/ja not_active Expired - Lifetime
- 1989-10-24 PH PH39398A patent/PH27450A/en unknown
-
1998
- 1998-09-11 JP JP10258447A patent/JP2983970B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4886811A (en) | Qunolyloxazole-2-ones useful as proteinkinase C inhibitors | |
JPH09176123A (ja) | アミノアルキル置換ベンゾ複素環化合物 | |
CN101541782A (zh) | 作为凝血酶受体拮抗剂的二环和三环衍生物 | |
JPH0561273B2 (sv) | ||
US4990519A (en) | Method of using quinolyloxazole-2-ones as proteinkinase C inhibitors | |
KR0166359B1 (ko) | 중추 신경계 약제로서 유용한 치환 시클로헥센 | |
US4999431A (en) | Process for preparing quinoline aldehyde and ketone derivatives | |
CA2214533C (en) | Quinolyloxazole-2-ones useful as proteinkinase c inhibitors | |
US5190957A (en) | Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones | |
EP1659112B1 (fr) | Dérivés d'arylpipérazine comme ligands sélectifs du récepteur D3 de la dopamine | |
US5061715A (en) | Prevention of glycoprotein enveloped virus infectivity by quinolyl- and isoquinolyloxazole-2-zones | |
US5750523A (en) | Pyridazinone derivatives | |
US5026861A (en) | Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones | |
JPH0529029B2 (sv) | ||
KR0168645B1 (ko) | 퀴놀릴옥사졸-2-온 및 이소퀴놀릴옥사졸-2-온의 다약제 내성 종양의 치료 용도 | |
JP3038032B2 (ja) | 血小板凝集抑制薬 | |
CA2099630A1 (en) | Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents | |
IE904078A1 (en) | Novel pyridyloxyazole-2-ones useful as proteinkinase¹c inhibitors | |
WO1998022443A1 (fr) | Derives de n-(imidazolylbutyle) benzenesulfonamide ayant une activite antithrombotique | |
CA3227149A1 (en) | Deuterated compounds | |
US5109010A (en) | Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones | |
JPH02311479A (ja) | キノリン誘導体 | |
JP2003513096A (ja) | スルタムおよびスルトンから誘導された抗生物質オキサゾリジノン | |
JPH10120632A (ja) | N−シクロアルキル−〔ω−(3,4−ジヒドロ−2−ナフタレニル)アルキル〕アミン誘導体及びそれを含有する医薬組成物 | |
MXPA06008313A (en) | Substituted quinolines and their use as mycobacterial inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void | ||
HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC. |